BioCentury
ARTICLE | Company News

Elan drug delivery, neurology, autoimmune news

January 31, 2011 8:00 AM UTC

Elan said that earlier this month it reduced headcount by 130 (10%) to about 1,200. Elan said a little less than half of the cuts came from R&D and primarily occurred at its South San Francisco, Calif...